• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. WEIGHT BASED ANTI TUBERCULAR THERAPY V/S HIGH DOSE ANTI TUBERCULAR THERAPY

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

WEIGHT BASED ANTI TUBERCULAR THERAPY V/S HIGH DOSE ANTI TUBERCULAR THERAPY

    Author

    • DR. BHUMIKA VAISHNAV, DR AVS SRIVATSAV, DR KARTHEEK MINNA
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Tuberculosis is a highly contagious disease caused due to Mycobacterium tuberculosis infection. Though the methods of treatment of the disease have been standardized since long, many people, especially in the developing countries, still succumb to it. According to recent statistical figures published by the World Health Organization (WHO), 10.4 million new cases of TB were reported worldwide in the year 2015 alone. Here we presented a case of 30-year-old female patient was brought to casualty with history of 5 episodes of generalized tonic-clonic seizures since morning. There was no postictal confusion. These complaints were associated with headache and nausea. There was no history of fever, blurring of vision, diplopia or altered sensorium. There was no history of trauma or similar episodes in the past. Patient is a known case of pulmonary tuberculosis, and has received anti tubercular therapy for 6 months, 7 years ago. Low concentrations of anti-TB drugs should be dealt with extreme caution as it may influence the pathogen’s drug susceptibility and the short-course treatment strategy for fighting TB. A better and easier way to overcome low serum concentrations of anti-TB drugs is to prescribe high doses for TB treatment, subject to prior verification of absence of adverse effects and cross drug resistance. Taking also into account the increase in adverse effects and the host/bacterial factors, It is becoming a critical point to identify if those patients in whom high-dose treatments are truly cost-effective.

  • XML
  • PDF 399.77 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 21
    • PDF Download: 80
European Journal of Molecular & Clinical Medicine
Volume 10, Issue 1 - Issue Serial Number 1
January 2023
Page 2002-2007
Files
  • XML
  • PDF 399.77 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 21
  • PDF Download: 80

APA

DR KARTHEEK MINNA, D. B. V. . D. A. S. (2023). WEIGHT BASED ANTI TUBERCULAR THERAPY V/S HIGH DOSE ANTI TUBERCULAR THERAPY. European Journal of Molecular & Clinical Medicine, 10(1), 2002-2007.

MLA

DR. BHUMIKA VAISHNAV, DR AVS SRIVATSAV, DR KARTHEEK MINNA. "WEIGHT BASED ANTI TUBERCULAR THERAPY V/S HIGH DOSE ANTI TUBERCULAR THERAPY". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 2002-2007.

HARVARD

DR KARTHEEK MINNA, D. B. V. . D. A. S. (2023). 'WEIGHT BASED ANTI TUBERCULAR THERAPY V/S HIGH DOSE ANTI TUBERCULAR THERAPY', European Journal of Molecular & Clinical Medicine, 10(1), pp. 2002-2007.

VANCOUVER

DR KARTHEEK MINNA, D. B. V. . D. A. S. WEIGHT BASED ANTI TUBERCULAR THERAPY V/S HIGH DOSE ANTI TUBERCULAR THERAPY. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 2002-2007.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus